Kirkland Counsels HealthCor Catalio Acquisition on Upsized $180 Million IPO
Kirkland & Ellis advised HealthCor Catalio Acquisition Corp., a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, on the pricing of its upsized initial public offering of 18,000,000 Class A ordinary shares at a price of $10 per share. The Company's sponsor is owned by affiliates of HealthCor Management, L.P., which manages approximately $2.7 billion in assets across long/short and long only healthcare funds, and Catalio Capital Management, LP, a private equity firm that invests in breakthrough biomedical technology companies. The Company will be listed on the Nasdaq Capital Market and trade under the ticker symbol "HCAQ" beginning on Jan. 27, 2021.
Read HealthCor’s press release
The Kirkland team was led by capital markets partners Christian Nagler and Debbie Yee and associates Noah Allen, Austin Elliott, Sami Ghubril and Sam Roberts; and tax partners Mike Beinus, Vivek Ratnam and Meredith Levy.
